Taking A Lesson From McDonald's
Myrtle Potter and Andre Kay, the COO of Genentech and Head of Global Marketing and Sales for Novartis AG, respectively, oversee the commercial operations of companies that differ considerably in the scale and experience of their sales and marketing organizations. But at Windhover Information Inc.'s recent Marketing Pharmaceutical Innovation conference in Philadelphia, the two struck very similar tones in a session on global branding. Both spoke with urgency about the need for drug companies to adopt global strategies for quickly building and sustaining the value of major products in an increasingly competitive environment.
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.